Article
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia.
Blood - 11 Nov 2021
Awada Hassan, Durmaz Arda, Gurnari Carmelo, Kishtagari Ashwin, Meggendorfer Manja, Kerr Cassandra M, Kuzmanovic Teodora, Durrani Jibran, Shreve Jacob, Nagata Yasunobu, Radivoyevitch Tomas, Advani Anjali S, Ravandi Farhad, Carraway Hetty E, Nazha Aziz, Haferlach Claudia, Saunthararajah Yogen, Scott Jacob, Visconte Valeria, Kantarjian Hagop, Kadia Tapan, Sekeres Mikkael A, Haferlach Torsten, Maciejewski Jaroslaw P
Abstract excerpt
Although genomic alterations drive the pathogenesis of acute myeloid leukemia (AML), traditional classifications are largely based on morphology, and prototypic genetic founder lesions define only a small proportion of AML patients. The historical subdivision of primary/de novo AML and secondary AML has shown to variably correlate with genetic patterns. The combinatorial complexity and heterogeneity of AML...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
